84 related articles for article (PubMed ID: 16652376)
21. GRB-7 facilitates HER-2/Neu-mediated signal transduction and tumor formation.
Bai T; Luoh SW
Carcinogenesis; 2008 Mar; 29(3):473-9. PubMed ID: 17916906
[TBL] [Abstract][Full Text] [Related]
22. PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor.
Litvinov IV; Antony L; Dalrymple SL; Becker R; Cheng L; Isaacs JT
Prostate; 2006 Sep; 66(12):1329-38. PubMed ID: 16835890
[TBL] [Abstract][Full Text] [Related]
23. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
[TBL] [Abstract][Full Text] [Related]
24. A potential target associated with both cancer and cancer stem cells: a combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes.
Liu Y; Lu WL; Guo J; Du J; Li T; Wu JW; Wang GL; Wang JC; Zhang X; Zhang Q
J Control Release; 2008 Jul; 129(1):18-25. PubMed ID: 18466993
[TBL] [Abstract][Full Text] [Related]
25. NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications.
Clementz AG; Rogowski A; Pandya K; Miele L; Osipo C
Breast Cancer Res; 2011 Jun; 13(3):R63. PubMed ID: 21679465
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
Li XF; Yan PJ; Shao ZM
Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247
[TBL] [Abstract][Full Text] [Related]
27. Suppression of growth and cancer-induced angiogenesis of aggressive human breast cancer cells (MDA-MB-231) on the chorioallantoic membrane of developing chicken embryos by E-peptide of pro-IGF-I.
Chen MJ; Chiou PP; Lin P; Lin CM; Siri S; Peck K; Chen TT
J Cell Biochem; 2007 Aug; 101(5):1316-27. PubMed ID: 17286280
[TBL] [Abstract][Full Text] [Related]
28. Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.
Hiraga T; Kizaka-Kondoh S; Hirota K; Hiraoka M; Yoneda T
Cancer Res; 2007 May; 67(9):4157-63. PubMed ID: 17483326
[TBL] [Abstract][Full Text] [Related]
29. The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells.
Mertens-Talcott SU; Chintharlapalli S; Li X; Safe S
Cancer Res; 2007 Nov; 67(22):11001-11. PubMed ID: 18006846
[TBL] [Abstract][Full Text] [Related]
30. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
Song Y; Shen K; He CX
Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518
[TBL] [Abstract][Full Text] [Related]
31. Antitumor activity of an oncolytic adenoviral-CD40 ligand (CD154) transgene construct in human breast cancer cells.
Gomes EM; Rodrigues MS; Phadke AP; Butcher LD; Starling C; Chen S; Chang D; Hernandez-Alcoceba R; Newman JT; Stone MJ; Tong AW
Clin Cancer Res; 2009 Feb; 15(4):1317-25. PubMed ID: 19228733
[TBL] [Abstract][Full Text] [Related]
32. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
Liu H; Zang C; Emde A; Planas-Silva MD; Rosche M; Kühnl A; Schulz CO; Elstner E; Possinger K; Eucker J
Eur J Pharmacol; 2008 Sep; 591(1-3):43-51. PubMed ID: 18588872
[TBL] [Abstract][Full Text] [Related]
33. Reduced tumorigenesis in mouse mammary cancer cells following inhibition of Pea3- or Erm-dependent transcription.
Firlej V; Ladam F; Brysbaert G; Dumont P; Fuks F; de Launoit Y; Benecke A; Chotteau-Lelievre A
J Cell Sci; 2008 Oct; 121(Pt 20):3393-402. PubMed ID: 18827017
[TBL] [Abstract][Full Text] [Related]
34. The coactivator activator CoAA regulates PEA3 group member transcriptional activity.
Verreman K; Baert JL; Verger A; Drobecq H; Ferreira E; de Launoit Y; Monte D
Biochem J; 2011 Nov; 439(3):469-77. PubMed ID: 21736557
[TBL] [Abstract][Full Text] [Related]
35. Negative regulation of fibroblast growth factor 10 (FGF-10) by polyoma enhancer activator 3 (PEA3).
Chioni AM; Grose R
Eur J Cell Biol; 2009 Jul; 88(7):371-84. PubMed ID: 19410332
[TBL] [Abstract][Full Text] [Related]
36. Function of PEA3 Ets transcription factors in mammary gland development and oncogenesis.
Kurpios NA; Sabolic NA; Shepherd TG; Fidalgo GM; Hassell JA
J Mammary Gland Biol Neoplasia; 2003 Apr; 8(2):177-90. PubMed ID: 14635793
[TBL] [Abstract][Full Text] [Related]
37. Transcriptional targeting of the HER-2/neu oncogene.
Wang SC; Hung MC
Drugs Today (Barc); 2000 Dec; 36(12):835-43. PubMed ID: 12845342
[TBL] [Abstract][Full Text] [Related]
38. [Transcription factors of the PEA3 group in mammary cancer].
Monté D; Baert JL; Laget MP; Defossez PA; Coutte L; Pelczar H; Angeli I; Dewitte F; Stéhelin D; De Launoit Y
Ann Endocrinol (Paris); 1995; 56(5):547-51. PubMed ID: 8597501
[TBL] [Abstract][Full Text] [Related]
39. The PEA3 group of ETS-related transcription factors. Role in breast cancer metastasis.
de Launoit Y; Chotteau-Lelievre A; Beaudoin C; Coutte L; Netzer S; Brenner C; Huvent I; Baert JL
Adv Exp Med Biol; 2000; 480():107-16. PubMed ID: 10959416
[TBL] [Abstract][Full Text] [Related]
40. The LIM domain protein LPP is a coactivator for the ETS domain transcription factor PEA3.
Guo B; Sallis RE; Greenall A; Petit MM; Jansen E; Young L; Van de Ven WJ; Sharrocks AD
Mol Cell Biol; 2006 Jun; 26(12):4529-38. PubMed ID: 16738319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
